Passage BIO, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Nichols Weston | — | Purchase | 19,783 | $6.99 | $138,283 | 611,804 | Sep 15, 2025 |
| Lynx1 Capital Management LP | — | Purchase | 49,302 | $5.74 | $282,993 | 525,273 | Jul 24, 2025 |
| ORBIMED ADVISORS LLC | — | Sale | 138,800 | $0.33 | $45,804 | 6,279,600 | Jun 24, 2025 |
| ORBIMED ADVISORS LLC | — | Sale | 78,049 | $0.34 | $26,537 | 6,807,523 | Apr 24, 2025 |
| OrbiMed Capital GP VII LLC | — | Sale | 77,090 | $0.33 | $25,440 | 6,885,572 | Apr 15, 2025 |
| Borthwick Kathleen | CFO | Sale | 3,183 | $0.53 | $1,687 | 41,283 | Feb 10, 2025 |
| ORBIMED ADVISORS LLC | — | Sale | 79,024 | $0.60 | $47,414 | 7,034,626 | Jan 13, 2025 |
| OrbiMed Capital GP VII LLC | — | Sale | 75,007 | $0.68 | $51,005 | 7,257,845 | Jan 6, 2025 |
| Lynx1 Capital Management LP | — | Purchase | 373,645 | $0.65 | $242,869 | 9,256,953 | Dec 27, 2024 |
| OrbiMed Capital GP VII LLC | — | Sale | 230,321 | $0.60 | $138,193 | 7,404,869 | Dec 20, 2024 |
| ORBIMED ADVISORS LLC | — | Sale | 8,015 | $0.80 | $6,412 | 7,635,270 | Dec 9, 2024 |
| OrbiMed Capital GP VII LLC | — | Sale | 20,903 | $0.82 | $17,140 | 7,697,466 | Dec 4, 2024 |
| Lynx1 Capital Management LP | — | Purchase | 167,055 | $0.71 | $118,609 | 8,854,008 | Nov 25, 2024 |
| ORBIMED ADVISORS LLC | — | Sale | 39,300 | $0.71 | $27,903 | 7,794,569 | Sep 19, 2024 |
| OrbiMed Capital GP VII LLC | — | Sale | 111,400 | $0.73 | $81,322 | 7,859,500 | Sep 16, 2024 |
| Forman Mark S | CHIEF MEDICAL OFFICER | Option Exercise | 5,000 | — | — | 50,269 | Feb 13, 2024 |
| Borthwick Kathleen | SVP, INTERIM CFO | Sale | 1,470 | $0.97 | $1,426 | 28,466 | Feb 10, 2024 |
| Borthwick Kathleen | SVP, Interim CFO | Option Exercise | 30,000 | — | — | 36,608 | Jan 2, 2024 |
| Forman Mark S | Chief Medical Officer | Sale | 15,813 | $0.91 | $14,390 | 45,269 | Dec 31, 2023 |
| Cale Edgar B. | GC & Corporate Secretary | Sale | 15,813 | $0.91 | $14,390 | 45,995 | Dec 31, 2023 |
| King Simona | Chief Financial Officer | Sale | 11,453 | $0.88 | $10,079 | 23,994 | Jul 28, 2023 |
| ORBIMED ADVISORS LLC | — | Purchase | 575,195 | $0.84 | $483,164 | 8,034,000 | Jun 27, 2023 |
| Fotopoulos Alexandros | Chief Technical Officer | Option Exercise | 12,500 | — | — | 32,745 | Jun 16, 2023 |
| King Simona | Chief Financial Officer | Sale | 2,053 | $1.05 | $2,156 | 2,053 | Apr 18, 2023 |
| Kapadia Sandip | — | Sale | 5,000 | $1.19 | $5,950 | — | Dec 1, 2022 |
| Fotopoulos Alexandros | Chief Technical Officer | Sale | 3,720 | $1.33 | $4,948 | 20,245 | Nov 22, 2022 |
| Toernsen Monika Maria | Chief Commercial Officer | Sale | 1,681 | $1.51 | $2,538 | 3,319 | Sep 15, 2022 |
| OrbiMed Capital GP VII LLC | — | Purchase | 303,500 | $1.94 | $588,790 | 6,841,423 | May 3, 2022 |
| Goldsmith Bruce A | CEO and President | Purchase | 10,000 | $3.15 | $31,500 | 15,983 | Mar 21, 2022 |
| OrbiMed Capital GP VII LLC | — | Purchase | 369,100 | $5.42 | $2,000,522 | 6,634,723 | Jan 20, 2022 |
| ORBIMED ADVISORS LLC | — | Purchase | 50,800 | $5.00 | $254,000 | 6,316,423 | Jan 20, 2022 |
| OrbiMed Capital GP VII LLC | — | Purchase | 43,300 | $5.11 | $221,263 | 6,265,623 | Jan 14, 2022 |
| OrbiMed Capital GP VII LLC | — | Purchase | 100,000 | $5.65 | $565,000 | 6,055,523 | Jan 13, 2022 |
| Quigley Jill M. | Chief Operating Officer | Option Exercise | 71,975 | $0.23 | $16,554 | 368,754 | Dec 8, 2021 |
| Morris Richard Steven | Chief Financial Officer | Purchase | 2,171 | $13.82 | $30,003 | 5,454 | May 21, 2021 |
| Goldsmith Bruce A | CEO and President | Purchase | 2,000 | $13.12 | $26,240 | 5,983 | May 21, 2021 |
| Romano Gary | Chief Medical Officer | Sale | 1,617 | $21.86 | $35,348 | — | Mar 15, 2021 |
| Quigley Jill M. | Chief Operating Officer | Sale | 1,300 | $30.01 | $39,013 | 295,284 | Jan 20, 2021 |
| Quigley Jill M. | Chief Operating Officer | Sale | 16,298 | $30.10 | $490,570 | 296,584 | Jan 14, 2021 |
| Countouriotis Athena | — | Purchase | 10,000 | $14.98 | $149,800 | 18,900 | Mar 24, 2020 |
| Ratcliffe Liam | — | Purchase | 2,800 | $18.00 | $50,400 | 2,800 | Mar 3, 2020 |
| OrbiMed Capital GP VII LLC | — | Purchase | 373,300 | $18.00 | $6,719,400 | 373,300 | Mar 3, 2020 |
| Versant Ventures VI GP, L.P. | — | C | 1,049,175 | — | — | 4,026,417 | Mar 3, 2020 |
| FHMLS IX, L.P. | — | C | 432,802 | — | — | 4,459,219 | Mar 3, 2020 |
| Woiwode Thomas | — | C | 2,977,242 | — | — | 2,977,242 | Mar 3, 2020 |
| Heron Patrick J | — | C | 2,977,242 | — | — | 2,977,242 | Mar 3, 2020 |
| Yamada Tadataka | — | Purchase | 6,500 | $18.00 | $117,000 | 656,149 | Mar 3, 2020 |
| Ratcliffe Liam | — | Purchase | 2,800 | $18.00 | $50,400 | 2,800 | Mar 3, 2020 |
| Quigley Jill M. | Chief Operating Officer | Purchase | 1,500 | $18.00 | $27,000 | 311,494 | Mar 3, 2020 |
| Morris Richard Steven | Chief Financial Officer | Purchase | 400 | $18.00 | $7,200 | 400 | Mar 3, 2020 |